New York State Common Retirement Fund Acquires 54,705 Shares of Pediatrix Medical Group, Inc. $MD

New York State Common Retirement Fund boosted its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 87.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,950 shares of the company’s stock after purchasing an additional 54,705 shares during the period. New York State Common Retirement Fund owned 0.13% of Pediatrix Medical Group worth $1,959,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of MD. Canada Pension Plan Investment Board acquired a new stake in shares of Pediatrix Medical Group in the second quarter valued at $83,000. Quantbot Technologies LP bought a new stake in Pediatrix Medical Group during the 2nd quarter worth about $99,000. Tower Research Capital LLC TRC increased its position in Pediatrix Medical Group by 219.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,685 shares of the company’s stock valued at $110,000 after acquiring an additional 5,278 shares in the last quarter. Cetera Investment Advisers bought a new position in shares of Pediatrix Medical Group in the second quarter worth about $145,000. Finally, Freedom Investment Management Inc. acquired a new position in shares of Pediatrix Medical Group during the second quarter worth approximately $151,000. Institutional investors and hedge funds own 97.71% of the company’s stock.

Insider Activity

In other Pediatrix Medical Group news, Director Michael A. Rucker sold 10,478 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $23.00, for a total value of $240,994.00. Following the sale, the director owned 59,101 shares in the company, valued at approximately $1,359,323. The trade was a 15.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Mark S. Ordan sold 23,000 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $22.41, for a total transaction of $515,430.00. Following the transaction, the chief executive officer directly owned 302,805 shares of the company’s stock, valued at $6,785,860.05. This represents a 7.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Monday, December 29th. Zacks Research cut Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Friday, January 23rd. UBS Group lifted their price objective on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Finally, Truist Financial boosted their price objective on shares of Pediatrix Medical Group from $17.00 to $24.00 and gave the company a “hold” rating in a report on Monday, November 10th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Pediatrix Medical Group has an average rating of “Hold” and an average price target of $21.00.

Pediatrix Medical Group Stock Performance

Shares of MD opened at $20.92 on Monday. The firm has a market cap of $1.80 billion, a P/E ratio of 11.01 and a beta of 0.76. Pediatrix Medical Group, Inc. has a twelve month low of $11.84 and a twelve month high of $24.99. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.83 and a current ratio of 1.83. The firm’s 50 day moving average price is $21.87 and its two-hundred day moving average price is $19.06.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.